Breaking News

Great Bay Bio Secures Series B Funding to Fuel Global Expansion

The funds will be used to advance GBB's AI-enabled drug development ecosystem and accelerate the global adoption of its innovative solutions.

Author Image

By: Charlie Sternberg

Associate Editor

Great Bay Bio (GBB) announced today the first close of its Series B financing round, led by a strategic investment institution and its affiliate, Tiger Jade Pebble Accelerator. The round also saw participation from new investors including a Hong Kong-based family office and the Hong Kong Science and Technology Parks Venture Fund, as well as continued support from existing investors.   The funds will be used to advance GBB’s AI-enabled drug development ecosystem and accelerate the global ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters